Abstract
Hypoxanthine arabinoside pharmacokinetics were measured during an adenine arabinoside continuous intravenous infusion and during hemodialysis in a patient with renal failure. Therapeutic guidelines for adenine arabinoside in renal failure are provided based on an elimination half-life of 4.7 h and a plasma clearance of 87.9 ml/min for the hypoxanthine metabolite.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bryan C. S., Stone W. J. Antimicrobial dosage in renal failure: a unifying nomogram. Clin Nephrol. 1977 Feb;7(2):81–84. [PubMed] [Google Scholar]
- Ramos E., Timmons R. F., Schimpff S. C. Inappropriate antidiuretic hormone following adenine arabinoside administration. Antimicrob Agents Chemother. 1979 Jan;15(1):142–144. doi: 10.1128/aac.15.1.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wagner J. G. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J Pharmacokinet Biopharm. 1976 Oct;4(5):443–467. doi: 10.1007/BF01062831. [DOI] [PubMed] [Google Scholar]
- Whitley R. J., Soong S. J., Dolin R., Galasso G. J., Ch'ien L. T., Alford C. A. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11;297(6):289–294. doi: 10.1056/NEJM197708112970601. [DOI] [PubMed] [Google Scholar]